Inspyr Therapeutics, Inc.
SEC CIK 1421204 · NSPX · last insider filing 2017-08-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hansen Bo Jesper | Director | filed 2014 - 2017 |
| Montgomery John Robison | Director | filed 2017 - 2017 |
| Grebow Peter E | Director | filed 2014 - 2017 |
| Ogilvie Scott Varde | Director | filed 2014 - 2017 |
| Thom Claire | Director | filed 2016 - 2016 |
| Buller Richard E | Director | filed 2016 - 2016 |
| Lowe Christopher P. | Director · President and CEO | filed 2016 - 2016 |
| Dionne Craig A | Director · CEO,CFO, President | filed 2014 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shazer Ronald L | Chief Medical Officer | filed 2016 - 2016 |
| Richerson Russell | COO, Secretary | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.